A Hong Kong University of Science and Technology (HKUST) research team has developed a catalytic enantioselective type II ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Kura Oncology won FDA priority review for its drug the day before announcing new data at ASCO 2025 showing remission in about ...

Tenpoint Therapeutics announced that the new drug application (NDA) for its presbyopia candidate, brimochol PF, has been ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

XP 8121 is a combination drug meant to better control hypothyroidism, in part by moving its common therapy, levothyroxine, ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

A pop-up overdose prevention tent is now running once a week in downtown St. John's. Overdose Awareness and Response St.

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...